U.S. Markets close in 48 mins

Lice Infestations Global Market and Pipeline Insights, 2020 - ResearchAndMarkets.com

The "Lice Infestations - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Lice Infestations Pipeline Insight, 2020 report outlays comprehensive insights of present clinical development scenario and growth prospects across the Lice Infestations market. A detailed picture of the Lice Infestations pipeline landscape is provided, which includes the disease overview and Lice Infestations treatment guidelines.

The assessment part of the report embraces in-depth Lice Infestations commercial assessment and clinical assessment of the Lice Infestations pipeline products from the pre-clinical developmental phase to the marketed phase.

In the report, a detailed description of the drug is proffered including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Lice Infestations collaborations, licensing, mergers and acquisition, funding, designations, and other product-related details.

The report provides insights into:

  • All of the companies that are developing therapies for the treatment of Lice Infestations with aggregate therapies developed by each company for the same.
  • Different therapeutic candidates segmented into early-stage, mid-stage and late stage of development for the Lice Infestations treatment.
  • Lice Infestations key players involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of Lice Infestations market.

Scope of the Report

  • The Lice Infestations report provides an overview of therapeutic pipeline activity and therapeutic assessment of the products by development stage, product type, route of administration, molecule type, and MOA type for Lice Infestations across the complete product development cycle, including all clinical and nonclinical stages.
  • It comprises of detailed profiles of Lice Infestations therapeutic products with key coverage of developmental activities, including technology, collaborations, licensing, mergers and acquisition, funding, designations and other product-related details
  • Detailed Lice Infestations research and development progress and trial details, results wherever available, are also included in the pipeline study.
  • Coverage of dormant and discontinued pipeline projects along with the reasons if available across Lice Infestations.

Key Topics Covered

1. Report Introduction

2. Lice Infestations

2.1. Overview

2.2. History

2.3. Lice Infestations Symptoms

2.4. Causes


2.6. Lice Infestations Diagnosis

2.6.1. Diagnostic Guidelines

3. Lice Infestations Current Treatment Patterns

3.1. Lice Infestations Treatment Guidelines

4. Lice Infestations - Analytical Perspective

4.1. In-depth Commercial Assessment

4.1.1. Lice Infestations companies collaborations, Licensing, Acquisition - Deal Value Trends Assessment Summary

4.1.2. Lice Infestations Collaboration Deals Company-Company Collaborations (Licensing / Partnering) Analysis Company-University Collaborations (Licensing / Partnering) Analysis Lice Infestations Acquisition Analysis

5. Therapeutic Assessment

5.1. Clinical Assessment of Pipeline Drugs

5.1.1. Assessment by Phase of Development

5.1.2. Assessment by Product Type (Mono / Combination) Assessment by Stage and Product Type

5.1.3. Assessment by Route of Administration Assessment by Stage and Route of Administration

5.1.4. Assessment by Molecule Type Assessment by Stage and Molecule Type

5.1.5. Assessment by MOA Assessment by Stage and MOA

5.1.6. Assessment by Target Assessment by Stage and Target

6. Lice Infestations Late Stage Products (Phase-III)

7. Lice Infestations Mid Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Lice Infestations Discontinued Products

13. Lice Infestations Product Profiles

13.1. Drug Name: Company

13.1.1. Product Description Product Overview Mechanism of action

13.1.2. Research and Development Clinical Studies

13.1.3. Product Development Activities Collaboration Agreements Acquisition Patent Detail

13.1.4. Tabulated Product Summary General Description Table

14. Lice Infestations Key Companies

15. Lice Infestations Key Products

16. Dormant and Discontinued Products

16.1. Dormant Products

16.1.1. Reasons for being dormant

16.2. Discontinued Products

16.2.1. Reasons for the discontinuation

17. Lice Infestations Unmet Needs

18. Lice Infestations Future Perspectives

19. Lice Infestations Analyst Review

20. Appendix

21. Report Methodology

21.1. Secondary Research

21.2. Expert Panel Validation

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/939vzu

View source version on businesswire.com: https://www.businesswire.com/news/home/20200702005357/en/


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900